GM-CSF-INDUCED GRANULOCYTIC MYELOID REGULATORY CELLS ARE ACTIVATED BY BACTERIAL LIPOPOLYSACCHARIDE TO SUPPRESS HUMAN T-CELL RESPONSES
- Authors: Gaponov A.M.1,2,3, Pisarev V.M.2,3, Tutelyan A.V.1,3,4
-
Affiliations:
- Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation
- Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
- Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being
- Department of Epidemiology of I. M. Sechenov First Moscow State Medical University of Ministry of Health of Russian Federation
- Issue: Vol 22, No 4 (2019)
- Pages: 1450-1453
- Section: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/1028-7221/article/view/119502
- DOI: https://doi.org/10.31857/S102872210007054-4
- ID: 119502
Cite item
Full Text
Abstract
About the authors
A. M. Gaponov
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation;Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology;
Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being
Author for correspondence.
Email: zorba@yandex.ru
MD, Head of the Laboratory of Infectious Immunology,
Moscow
Russian FederationV. M. Pisarev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology;Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being
Email: fake@neicon.ru
MD, Prof., Head of the Laboratory of Molecular Mechanisms the Development of Critical States,
Moscow
Russian FederationA. V. Tutelyan
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation;Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being;
Department of Epidemiology of I. M. Sechenov First Moscow State Medical University of Ministry
of Health of Russian Federation
Email: fake@neicon.ru
ORCID iD: 0000-0002-2706-6689
MD, Prof., Corresponding Member of the Russian Academy of Sciences; Head, Laboratory of Healthcare-Associated Infections,
Moscow
Russian FederationReferences
- Veglia F., Perego M., Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat. Immunol. 2018, 19(2), 108–119.
- Tamadaho R. S. E., Hoerauf A., Layland L. E. Immunomodulatory eff ects of myeloid-derived suppressor cells in diseases: Role in cancer and infections. Immunobiology 2018, 223(4–5), 432–442.
- Kamp V. M., Leentjens J., Pillay J., Langereis J. D., de Kleij n S., Kox M., Netea M. G., Pickkers P., Koenderman L. Modulation of granulocyte kinetics by GMCSF/IFN-γ in a human LPS rechallenge model. J. Leukoc. Biol. 2013, 94(3), 513–520.
- Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., Geilich M., Winkels G., Traggiai E., Casati A., Grassi F., Bronte V. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010, 40(1), 22–35.
- Hattori N., Saiki S., Imai Y. Regulation by mitophagy. Int. J. Biochem. Cell Biol. 2014, 53, 147–150.
Supplementary files
